Your search for "feliway" return 9 results.
Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market
Adapting to life in an increasingly urbanised world can be stressful for dogs and cats. Ceva’s innovative treatments for behavioural problems help to optimise the lives people share with their pets.
Ceva today announced its commitment to Fear Free,™ an innovative initiative developed by “America’s Veterinarian” Dr. Marty Becker to in his words, “take the pet out of petrified and get pets back int...
Libourne, France, 22 July, 2013: Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates. C...
14% growth pushes sales beyond 600 M€ for first time
Double-digit growth confirms long term upward trend
Company continues to expand its North American operations with entry into Canada.
With the development of FELIWAY® and ADAPTIL®, Ceva opened the way to a completely new approach of feline and canine behaviour and well-being.
If there is one field in which Ceva Santé Animale has demonstrated the full extent of its innovation capacities, it is that of companion animals.